Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health, Reducing Psychiatric Hospitalizations and Work Absences April 28, 2026 Rebecca Shoemaker New, large-scale research involving nearly 100,000 individuals has unveiled a significant correlation between the use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus),…
